First National Bank & Trust CO Of Newtown Bristol Myers Squibb CO Transaction History

First National Bank & Trust CO Of Newtown

  • $491 Million
  • Q2 2024

A detailed history of First National Bank & Trust CO Of Newtown transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First National Bank & Trust CO Of Newtown holds 27,708 shares of BMY stock, worth $1.4 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
27,708
Previous 30,108 7.97%
Holding current value
$1.4 Million
Previous $1.63 Million 29.53%
% of portfolio
0.23%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
SELL
$40.25 - $52.99 $96,600 - $127,176
-2,400 Reduced 7.97%
27,708 $1.15 Million
Q1 2024

Apr 29, 2024
SELL
$47.98 - $54.4 $7,292 - $8,268
-152 Reduced 0.5%
30,108 $1.63 Million
Q4 2023

Jan 31, 2024
SELL
$48.48 - $57.85 $28,845 - $34,420
-595 Reduced 1.93%
30,260 $1.55 Million
Q3 2023

Nov 01, 2023
SELL
$57.89 - $64.73 $6,078 - $6,796
-105 Reduced 0.34%
30,855 $1.79 Million
Q2 2023

Jul 31, 2023
SELL
$63.71 - $70.74 $1,592 - $1,768
-25 Reduced 0.08%
30,960 $1.98 Million
Q1 2023

May 04, 2023
SELL
$65.71 - $74.53 $32,197 - $36,519
-490 Reduced 1.56%
30,985 $2.15 Million
Q4 2022

Jan 31, 2023
SELL
$68.48 - $81.09 $10,819 - $12,812
-158 Reduced 0.5%
31,475 $2.26 Million
Q3 2022

Nov 09, 2022
SELL
$0.13 - $76.84 $3 - $2,305
-30 Reduced 0.09%
31,633 $2.25 Million
Q2 2022

Aug 08, 2022
SELL
$72.62 - $79.98 $12,345 - $13,596
-170 Reduced 0.53%
31,663 $2.44 Million
Q1 2022

May 10, 2022
BUY
$61.48 - $73.72 $2,766 - $3,317
45 Added 0.14%
31,833 $2.32 Million
Q4 2021

Jan 31, 2022
SELL
$53.63 - $62.52 $13,139 - $15,317
-245 Reduced 0.76%
31,788 $1.98 Million
Q3 2021

Oct 20, 2021
SELL
$59.17 - $69.31 $134,315 - $157,333
-2,270 Reduced 6.62%
32,033 $1.9 Million
Q2 2021

Aug 06, 2021
SELL
$61.91 - $67.42 $13,929 - $15,169
-225 Reduced 0.65%
34,303 $2.29 Million
Q1 2021

May 06, 2021
BUY
$59.34 - $66.74 $3,560 - $4,004
60 Added 0.17%
34,528 $2.18 Million
Q4 2020

Feb 11, 2021
SELL
$57.74 - $65.43 $78,179 - $88,592
-1,354 Reduced 3.78%
34,468 $2.14 Million
Q3 2020

Nov 06, 2020
BUY
$57.43 - $63.64 $17,516 - $19,410
305 Added 0.86%
35,822 $2.16 Million
Q2 2020

Aug 04, 2020
SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 0.28%
35,517 $2.09 Million
Q1 2020

Apr 23, 2020
SELL
$46.4 - $67.43 $51,179 - $74,375
-1,103 Reduced 3.0%
35,617 $1.99 Million
Q4 2019

Jan 30, 2020
SELL
$49.21 - $64.19 $15,993 - $20,861
-325 Reduced 0.88%
36,720 $2.36 Million
Q3 2019

Nov 06, 2019
SELL
$42.77 - $50.71 $13,900 - $16,480
-325 Reduced 0.87%
37,045 $1.88 Million
Q2 2019

Jul 17, 2019
SELL
$44.62 - $49.34 $33,018 - $36,511
-740 Reduced 1.94%
37,370 $1.69 Million
Q1 2019

May 07, 2019
SELL
$45.12 - $53.8 $9,024 - $10,760
-200 Reduced 0.52%
38,110 $1.82 Million
Q4 2018

Jan 18, 2019
SELL
$48.76 - $63.23 $9,020 - $11,697
-185 Reduced 0.48%
38,310 $1.99 Million
Q3 2018

Oct 30, 2018
SELL
$55.19 - $62.25 $75,941 - $85,656
-1,376 Reduced 3.45%
38,495 $2.39 Million
Q2 2018

Jul 31, 2018
SELL
$50.53 - $62.98 $19,201 - $23,932
-380 Reduced 0.94%
39,871 $2.21 Million
Q1 2018

Apr 27, 2018
SELL
$59.92 - $68.98 $20,972 - $24,143
-350 Reduced 0.86%
40,251 $2.55 Million
Q4 2017

Jan 17, 2018
SELL
$59.94 - $65.35 $61,738 - $67,310
-1,030 Reduced 2.47%
40,601 $2.49 Million
Q3 2017

Oct 25, 2017
BUY
$55.23 - $63.74 $2.3 Million - $2.65 Million
41,631
41,631 $2.65 Million

Others Institutions Holding BMY

# of Institutions
2,478
Shares Held
1.49B
Call Options Held
26M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $107B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First National Bank & Trust CO Of Newtown Portfolio

Follow First National Bank & Trust CO Of Newtown and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank & Trust CO Of Newtown, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank & Trust CO Of Newtown with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email